Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

United States

MedStar Washington Hospital Center, Washington D.C., District of Columbia

Moffitt Cancer Center, Tampa, Florida

Massachusetts General Hospital, Boston, Massachusetts

University of Michigan, Ann Arbor, Michigan

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania